| 372 |
[2021 Jul;45(4)] Dose-Dependent Effect of Smoking on Risk of Diabetes Remains after Smoking Cessation: A Nationwide Population-Based Cohort Study in Korea
|
|
2022.07.15 |
204 |
| 371 |
[2021 Jul;45(4)] Study on Risk Factors of Peripheral Neuropathy in Type 2 Diabetes Mellitus and Establishment of Prediction Model
|
|
2022.07.15 |
180 |
| 370 |
[2021 Jul;45(4)] Development and Validation of a Deep Learning Based Diabetes Prediction System Using a Nationwide Population-Based Cohort
|
|
2022.07.15 |
179 |
| 369 |
[2021 Jul;45(4)] Cardiovascular Safety of Sodium Glucose Cotransporter 2 Inhibitors as Add-on to Metformin Monotherapy in Patients with Type 2 Diabetes Mellitus
|
|
2022.07.15 |
190 |
| 368 |
[2021 Jul;45(4)] Management of Cardiovascular Risk in Perimenopausal Women with Diabetes
|
|
2022.07.15 |
189 |
| 367 |
[2021 Jul;45(4)] Computed Tomography-Derived Myosteatosis and Metabolic Disorders
|
|
2022.07.15 |
178 |
| 366 |
[2021 Jul;45(4)] 2021 Clinical Practice Guidelines for Diabetes Mellitus in Korea
|
|
2022.07.15 |
195 |
| 365 |
[2021 May;45(3)] MondoA Is Required for Normal Myogenesis and Regulation of the Skeletal Muscle Glycogen Content in Mice
|
|
2022.07.15 |
184 |
| 364 |
[2021 May;45(3)] Use of Renin-Angiotensin-Aldosterone System Inhibitors and Severe COVID-19 Outcomes in Patients with Hypertension: A Nationwide Cohort Study
|
|
2022.07.15 |
199 |
| 363 |
[2021 May;45(3)] Distinct Dose-Dependent Association of Free Fatty Acids with Diabetes Development in Nonalcoholic Fatty Liver Disease Patients
|
|
2022.07.15 |
189 |
| 362 |
[2021 May;45(3)] Relationships between Islet-Specific Autoantibody Titers and the Clinical Characteristics of Patients with Diabetes Mellitus
|
|
2022.07.15 |
184 |
| 361 |
[2021 May;45(3)] Reducing Carbohydrate from Individual Sources Has Differential Effects on Glycosylated Hemoglobin in Type 2 Diabetes Mellitus Patients on Moderate Low-Carbohydrate Diets
|
|
2022.07.15 |
214 |
| 360 |
[2021 May;45(3)] Increased Risk of Cardiovascular Disease and Mortality in Patients with Diabetes and Coexisting Depression: A Nationwide Population-Based Cohort Study
|
|
2022.07.15 |
170 |
| 359 |
[2021 May;45(3)] Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study
|
|
2022.07.15 |
191 |
| 358 |
[2021 May;45(3)] Association between Sleep Quality and Painless Diabetic Peripheral Neuropathy Assessed by Current Perception Threshold in Type 2 Diabetes Mellitus
|
|
2022.07.15 |
183 |
| 357 |
[2021 May;45(3)] Association of Urinary N-Acetyl-β-D-Glucosaminidase with Cardiovascular Autonomic Neuropathy in Type 1 Diabetes Mellitus without Nephropathy
|
|
2022.07.15 |
198 |
| 356 |
[2021 May;45(3)] Effect of Dapagliflozin as an Add-on Therapy to Insulin on the Glycemic Variability in Subjects with Type 2 Diabetes Mellitus (DIVE): A Multicenter, Placebo-Controlled, Double-Blind, Randomized Study
|
|
2022.07.15 |
188 |
| 355 |
[2021 May;45(3)] Lobeglitazone: A Novel Thiazolidinedione for the Management of Type 2 Diabetes Mellitus
|
|
2022.07.15 |
193 |
| 354 |
[2021 May;45(3)] Non-Insulin Antidiabetes Treatment in Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis
|
|
2022.07.15 |
177 |
| 353 |
[2021 May;45(3)] Hyperinsulinemia in Obesity, Inflammation, and Cancer
|
|
2022.07.15 |
182 |
